QA: Johnson Johnson in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000200406_2022_Johnson_Johnson.pdf

Logs

Graph

Absolute values for 0000200406, Johnson Johnson

  xvar xval
0 AssetsCurrent 51,237,000,000
1 IntangibleAssetsNetIncludingGoodwill 89,795,000,000
2 PropertyPlantAndEquipmentNet 18,766,000,000
3 remainder_Assets 15,096,000,000
4 LiabilitiesCurrent 42,493,000,000
5 LiabilitiesNoncurrent 44,579,000,000
6 remainder_Liabilities 24,544,000,000
7 CostOfGoodsAndServicesSold 28,427,000,000
8 SellingGeneralAndAdministrativeExpense 22,085,587,822
9 ResearchAndDevelopmentExpense 12,170,922,184
10 remainder_Expenses 2,347,473,123
11 remainder_Revenues 82,586,988,541
12 remainder_NetIncome -2,756,669,365
13 remainder_ComprehensiveNetIncome 488,329,847
  yvar yval
0 Assets 174,894,000,000
1 Liabilities 111,616,000,000
2 Expenses 65,030,983,129
3 Revenues 82,586,988,541
4 StockholdersEquity 63,278,000,000
5 NetIncome 14,799,336,047
6 ComprehensiveNetIncome 15,043,500,970
7 BaseVar 218,686,485,441
8 EconomicCapitalRatiobeforeLimitedLiability 1.07
9 EconomicCapitalRatio 2.36

Edgar->Model Mapping

Feature Distribution

Change over Time